HEADER HORMONE RECEPTOR/PEPTIDE 23-SEP-15 5DXB TITLE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX TITLE 2 WITH STAPLED PEPTIDE SRC2-P1 AND ESTRADIOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ESTROGEN RECEPTOR; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 12 GROUP A MEMBER 1; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES; COMPND 15 MOL_ID: 3; COMPND 16 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 2; COMPND 17 CHAIN: D, E; COMPND 18 SYNONYM: NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75,BHLHE75, COMPND 19 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: ESR1, ESR, NR3A1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606 KEYWDS ESTROGEN RECEPTOR ALPHA, SOMATIC MUTATAION, STAPLED PEPTIDE, PEPTIDE KEYWDS 2 MIMETIC, HORMONE RECEPTOR, BREAST CANCER, HORMONE RECEPTOR-PEPTIDE KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.W.FANNING,T.E.SPELTZ,C.G.MAYNE,E.TAJKHORSHID,G.L.GREENE,T.W.MOORE REVDAT 4 19-FEB-20 5DXB 1 REMARK SITE REVDAT 3 27-NOV-19 5DXB 1 REMARK REVDAT 2 06-SEP-17 5DXB 1 REMARK REVDAT 1 27-JUL-16 5DXB 0 JRNL AUTH T.E.SPELTZ,S.W.FANNING,C.G.MAYNE,C.FOWLER,E.TAJKHORSHID, JRNL AUTH 2 G.L.GREENE,T.W.MOORE JRNL TITL STAPLED PEPTIDES WITH GAMMA-METHYLATED HYDROCARBON CHAINS JRNL TITL 2 FOR THE ESTROGEN RECEPTOR/COACTIVATOR INTERACTION. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 55 4252 2016 JRNL REFN ESSN 1521-3773 JRNL PMID 26928945 JRNL DOI 10.1002/ANIE.201510557 REMARK 2 REMARK 2 RESOLUTION. 2.08 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.08 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.9 REMARK 3 NUMBER OF REFLECTIONS : 29399 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1502 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 27.5959 - 4.6123 0.97 2716 141 0.1601 0.1725 REMARK 3 2 4.6123 - 3.6636 0.99 2712 155 0.1425 0.1701 REMARK 3 3 3.6636 - 3.2013 0.99 2696 157 0.1689 0.2134 REMARK 3 4 3.2013 - 2.9089 0.99 2708 146 0.1885 0.2401 REMARK 3 5 2.9089 - 2.7006 0.99 2692 157 0.1962 0.2304 REMARK 3 6 2.7006 - 2.5415 0.99 2668 154 0.2027 0.2359 REMARK 3 7 2.5415 - 2.4143 0.99 2714 133 0.1991 0.2550 REMARK 3 8 2.4143 - 2.3093 0.98 2658 138 0.2050 0.2498 REMARK 3 9 2.3093 - 2.2204 0.91 2483 115 0.2074 0.2179 REMARK 3 10 2.2204 - 2.1438 0.78 2131 106 0.2019 0.2389 REMARK 3 11 2.1438 - 2.0768 0.64 1719 100 0.2212 0.2602 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3959 REMARK 3 ANGLE : 1.434 5358 REMARK 3 CHIRALITY : 0.072 629 REMARK 3 PLANARITY : 0.005 661 REMARK 3 DIHEDRAL : 15.522 1528 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESSEQ -10:9999) REMARK 3 ORIGIN FOR THE GROUP (A): 15.8361 -1.2229 5.1421 REMARK 3 T TENSOR REMARK 3 T11: 0.1503 T22: 0.1571 REMARK 3 T33: 0.0997 T12: -0.0074 REMARK 3 T13: 0.0072 T23: -0.0094 REMARK 3 L TENSOR REMARK 3 L11: 2.5374 L22: 1.2738 REMARK 3 L33: 0.9944 L12: 0.0068 REMARK 3 L13: -0.3914 L23: 0.0382 REMARK 3 S TENSOR REMARK 3 S11: 0.0115 S12: 0.0597 S13: 0.0319 REMARK 3 S21: -0.0342 S22: -0.0127 S23: -0.0299 REMARK 3 S31: -0.0453 S32: -0.0400 S33: 0.0020 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESSEQ -10:9999) REMARK 3 ORIGIN FOR THE GROUP (A): 6.7350 -1.1794 29.6363 REMARK 3 T TENSOR REMARK 3 T11: 0.2143 T22: 0.1913 REMARK 3 T33: 0.1552 T12: -0.0066 REMARK 3 T13: 0.0494 T23: -0.0192 REMARK 3 L TENSOR REMARK 3 L11: 2.2708 L22: 1.7590 REMARK 3 L33: 3.9182 L12: -0.3799 REMARK 3 L13: 1.0888 L23: -0.5526 REMARK 3 S TENSOR REMARK 3 S11: -0.0351 S12: -0.1056 S13: -0.0922 REMARK 3 S21: 0.2190 S22: 0.0048 S23: -0.0568 REMARK 3 S31: -0.0043 S32: 0.2356 S33: 0.0240 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DXB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213969. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-AUG-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29401 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.077 REMARK 200 RESOLUTION RANGE LOW (A) : 27.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 2.1700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3,350, 200 MM MGCL2, 100 MM REMARK 280 TRIS PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.96950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -18.40315 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 55.28969 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 294 REMARK 465 ASP A 295 REMARK 465 PRO A 296 REMARK 465 MET A 297 REMARK 465 ILE A 298 REMARK 465 LYS A 299 REMARK 465 ARG A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 LEU A 306 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 GLU A 470 REMARK 465 GLU A 471 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 MET B 294 REMARK 465 ASP B 295 REMARK 465 PRO B 296 REMARK 465 MET B 297 REMARK 465 ILE B 298 REMARK 465 LYS B 299 REMARK 465 ARG B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 LEU B 306 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 LYS B 472 REMARK 465 VAL B 533 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 465 ACE E 1 REMARK 465 NH2 E 13 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 423 CG CD OE1 OE2 REMARK 470 MET A 437 CG SD CE REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 ASP A 473 CG OD1 OD2 REMARK 470 GLU A 523 CG CD OE1 OE2 REMARK 470 LEU B 310 CG CD1 CD2 REMARK 470 GLU B 330 CG CD OE1 OE2 REMARK 470 PHE B 337 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 397 CG CD OE1 OE2 REMARK 470 ASP B 473 CG OD1 OD2 REMARK 470 GLU B 523 CG CD OE1 OE2 REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 HIS E 2 N CA CB CG ND1 CD2 CE1 REMARK 470 HIS E 2 NE2 REMARK 470 SER E 12 CA C O CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 353 O3 EST A 1000 1.80 REMARK 500 OE1 GLU B 353 O3 EST B 601 1.81 REMARK 500 OE1 GLU A 419 NZ LYS A 531 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP A 411 NH2 ARG D 7 2645 1.57 REMARK 500 O HOH A 1166 O HOH B 753 1554 2.05 REMARK 500 OH TYR A 328 ND2 ASN B 359 1554 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS D 6 NE2 HIS D 6 CD2 -0.082 REMARK 500 LEU E 5 CA LEU E 5 C -0.179 REMARK 500 HIS E 6 NE2 HIS E 6 CD2 -0.069 REMARK 500 HIS E 6 CA HIS E 6 C -0.177 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 411 CB - CG - OD2 ANGL. DEV. = 6.9 DEGREES REMARK 500 HIS E 6 CA - CB - CG ANGL. DEV. = -12.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 459 57.37 -106.78 REMARK 500 THR A 460 5.46 -162.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EST A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EST B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Ligand NH2 D 13 bound to SER D REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues MK8 D 4 and 66D D 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide LYS E 3 and MK8 E 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues MK8 E 4 and 66D E 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide MK8 E 4 and LEU E 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ARG E 7 and 66D E 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 66D E 8 and LEU E 9 DBREF 5DXB A 297 554 UNP P03372 ESR1_HUMAN 297 554 DBREF 5DXB B 297 554 UNP P03372 ESR1_HUMAN 124 381 DBREF 5DXB D 2 12 UNP Q15596 NCOA2_HUMAN 687 697 DBREF 5DXB E 2 12 UNP Q15596 NCOA2_HUMAN 687 697 SEQADV 5DXB MET A 294 UNP P03372 INITIATING METHIONINE SEQADV 5DXB ASP A 295 UNP P03372 EXPRESSION TAG SEQADV 5DXB PRO A 296 UNP P03372 EXPRESSION TAG SEQADV 5DXB SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 5DXB MET B 294 UNP P03372 INITIATING METHIONINE SEQADV 5DXB ASP B 295 UNP P03372 EXPRESSION TAG SEQADV 5DXB PRO B 296 UNP P03372 EXPRESSION TAG SEQADV 5DXB SER B 537 UNP P03372 TYR 364 ENGINEERED MUTATION SEQADV 5DXB ACE D 1 UNP Q15596 ACETYLATION SEQADV 5DXB MK8 D 4 UNP Q15596 ILE 689 CONFLICT SEQADV 5DXB 66D D 8 UNP Q15596 LEU 693 CONFLICT SEQADV 5DXB NH2 D 13 UNP Q15596 AMIDATION SEQADV 5DXB ACE E 1 UNP Q15596 ACETYLATION SEQADV 5DXB MK8 E 4 UNP Q15596 ILE 689 CONFLICT SEQADV 5DXB 66D E 8 UNP Q15596 LEU 693 CONFLICT SEQADV 5DXB NH2 E 13 UNP Q15596 AMIDATION SEQRES 1 A 261 MET ASP PRO MET ILE LYS ARG SER LYS LYS ASN SER LEU SEQRES 2 A 261 ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU SEQRES 3 A 261 LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP SEQRES 4 A 261 PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU SEQRES 5 A 261 LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE SEQRES 6 A 261 ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR SEQRES 7 A 261 LEU HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU SEQRES 8 A 261 GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU SEQRES 9 A 261 HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU SEQRES 10 A 261 ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU SEQRES 11 A 261 ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG SEQRES 12 A 261 MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SEQRES 13 A 261 SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SEQRES 14 A 261 SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE SEQRES 15 A 261 HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS SEQRES 16 A 261 LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS SEQRES 17 A 261 GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE SEQRES 18 A 261 ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER SEQRES 19 A 261 MET LYS SCH LYS ASN VAL VAL PRO LEU SER ASP LEU LEU SEQRES 20 A 261 LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SEQRES 21 A 261 SER SEQRES 1 B 261 MET ASP PRO MET ILE LYS ARG SER LYS LYS ASN SER LEU SEQRES 2 B 261 ALA LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU SEQRES 3 B 261 LEU ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP SEQRES 4 B 261 PRO THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU SEQRES 5 B 261 LEU THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE SEQRES 6 B 261 ASN TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR SEQRES 7 B 261 LEU HIS ASP GLN VAL HIS LEU LEU GLU CYS ALA TRP LEU SEQRES 8 B 261 GLU ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU SEQRES 9 B 261 HIS PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU SEQRES 10 B 261 ASP ARG ASN GLN GLY LYS CYS VAL GLU GLY MET VAL GLU SEQRES 11 B 261 ILE PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG SEQRES 12 B 261 MET MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SEQRES 13 B 261 SER ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SEQRES 14 B 261 SER SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE SEQRES 15 B 261 HIS ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS SEQRES 16 B 261 LEU MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS SEQRES 17 B 261 GLN ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE SEQRES 18 B 261 ARG HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER SEQRES 19 B 261 MET LYS CYS LYS ASN VAL VAL PRO LEU SER ASP LEU LEU SEQRES 20 B 261 LEU GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SEQRES 21 B 261 SER SEQRES 1 D 13 ACE HIS LYS MK8 LEU HIS ARG 66D LEU GLN ASP SER NH2 SEQRES 1 E 13 ACE HIS LYS MK8 LEU HIS ARG 66D LEU GLN ASP SER NH2 MODRES 5DXB SCH A 530 CYS MODIFIED RESIDUE HET SCH A 530 8 HET ACE D 1 3 HET MK8 D 4 9 HET 66D D 8 10 HET NH2 D 13 1 HET MK8 E 4 9 HET 66D E 8 10 HET EST A1000 20 HET EST B 601 20 HET GOL B 602 14 HET GOL B 603 14 HET CL B 604 1 HETNAM SCH S-METHYL-THIO-CYSTEINE HETNAM ACE ACETYL GROUP HETNAM MK8 2-METHYL-L-NORLEUCINE HETNAM 66D (4R)-2,4-DIMETHYL-L-NORLEUCINE HETNAM NH2 AMINO GROUP HETNAM EST ESTRADIOL HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 SCH C4 H9 N O2 S2 FORMUL 3 ACE C2 H4 O FORMUL 3 MK8 2(C7 H15 N O2) FORMUL 3 66D 2(C8 H17 N O2) FORMUL 3 NH2 H2 N FORMUL 5 EST 2(C18 H24 O2) FORMUL 7 GOL 2(C3 H8 O3) FORMUL 9 CL CL 1- FORMUL 10 HOH *163(H2 O) HELIX 1 AA1 THR A 311 GLU A 323 1 13 HELIX 2 AA2 SER A 338 LYS A 362 1 25 HELIX 3 AA3 GLY A 366 LEU A 370 5 5 HELIX 4 AA4 THR A 371 SER A 395 1 25 HELIX 5 AA5 ARG A 412 LYS A 416 1 5 HELIX 6 AA6 MET A 421 ASN A 439 1 19 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 GLY A 457 PHE A 461 5 5 HELIX 9 AA9 ASP A 473 ALA A 493 1 21 HELIX 10 AB1 THR A 496 LYS A 531 1 36 HELIX 11 AB2 SER A 537 HIS A 547 1 11 HELIX 12 AB3 THR B 311 ALA B 322 1 12 HELIX 13 AB4 SER B 338 LYS B 362 1 25 HELIX 14 AB5 THR B 371 SER B 395 1 25 HELIX 15 AB6 ASN B 413 VAL B 418 5 6 HELIX 16 AB7 MET B 421 ASN B 439 1 19 HELIX 17 AB8 GLN B 441 SER B 456 1 16 HELIX 18 AB9 HIS B 474 ALA B 493 1 20 HELIX 19 AC1 THR B 496 ASN B 532 1 37 HELIX 20 AC2 SER B 537 ALA B 546 1 10 HELIX 21 AC3 LYS D 3 LEU D 9 1 7 HELIX 22 AC4 LYS E 3 LEU E 9 1 7 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C LYS A 529 N SCH A 530 1555 1555 1.32 LINK C SCH A 530 N LYS A 531 1555 1555 1.31 LINK C ACE D 1 N HIS D 2 1555 1555 1.32 LINK C LYS D 3 N MK8 D 4 1555 1555 1.31 LINK C MK8 D 4 N LEU D 5 1555 1555 1.34 LINK CE MK8 D 4 CE 66D D 8 1555 1555 1.38 LINK C ARG D 7 N 66D D 8 1555 1555 1.36 LINK C 66D D 8 N LEU D 9 1555 1555 1.32 LINK C SER D 12 N NH2 D 13 1555 1555 1.30 LINK C LYS E 3 N MK8 E 4 1555 1555 1.30 LINK C MK8 E 4 N LEU E 5 1555 1555 1.39 LINK CE MK8 E 4 CE 66D E 8 1555 1555 1.38 LINK C ARG E 7 N 66D E 8 1555 1555 1.40 LINK C 66D E 8 N LEU E 9 1555 1555 1.32 SITE 1 AC1 6 MET A 343 LEU A 346 GLU A 353 ARG A 394 SITE 2 AC1 6 HIS A 524 LEU A 525 SITE 1 AC2 8 MET B 343 LEU B 346 GLU B 353 LEU B 387 SITE 2 AC2 8 ARG B 394 GLY B 521 HIS B 524 HOH B 707 SITE 1 AC3 3 ASN B 407 LEU B 408 LEU B 409 SITE 1 AC4 6 ASN B 439 GLN B 441 GLU B 444 MET B 490 SITE 2 AC4 6 ALA B 493 ARG B 503 SITE 1 AC5 4 ARG A 352 HOH A1159 ARG B 352 HOH B 718 SITE 1 AC6 1 SER D 12 SITE 1 AC7 10 GLU A 542 HOH A1107 TYR B 331 LYS D 3 SITE 2 AC7 10 LEU D 5 HIS D 6 ARG D 7 LEU D 9 SITE 3 AC7 10 GLN D 10 ASP D 11 SITE 1 AC8 8 GLU B 380 LEU B 539 GLU B 542 HIS E 2 SITE 2 AC8 8 LEU E 5 HIS E 6 ARG E 7 66D E 8 SITE 1 AC9 10 ILE B 358 LEU B 539 GLU B 542 LYS E 3 SITE 2 AC9 10 LEU E 5 HIS E 6 ARG E 7 LEU E 9 SITE 3 AC9 10 GLN E 10 ASP E 11 SITE 1 AD1 7 LEU B 539 GLU B 542 LYS E 3 HIS E 6 SITE 2 AD1 7 ARG E 7 66D E 8 LEU E 9 SITE 1 AD2 9 PRO A 333 ILE B 358 LYS E 3 MK8 E 4 SITE 2 AD2 9 LEU E 5 HIS E 6 LEU E 9 GLN E 10 SITE 3 AD2 9 ASP E 11 SITE 1 AD3 7 ILE B 358 MK8 E 4 LEU E 5 HIS E 6 SITE 2 AD3 7 ARG E 7 GLN E 10 ASP E 11 CRYST1 56.013 85.939 58.272 90.00 108.41 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017853 0.000000 0.005943 0.00000 SCALE2 0.000000 0.011636 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018087 0.00000